Core Viewpoint - The company, Aedus Medical, plans to raise up to $7 million through an IPO, with a proposed share price range of $7 to $9, leading to a market valuation of approximately $87 million [1] Company Overview - Aedus Medical, established in 2003, is based in Hong Kong and operates as a medical device and software procurement company [1] - The company sells medical devices and software to distributors and medical institutions in Hong Kong and mainland China [1] Product Offerings - Aedus Medical's product portfolio includes infusion pumps, anesthetic laryngoscopes, portable X-ray machines, and automated external defibrillators [1] - The company has developed proprietary medical software, including preclinical imaging post-processing software Prim and MRI analysis software iMRIPlus [1] Financial Performance - For the 12 months ending March 31, 2025, Aedus Medical reported projected revenues of $25 million [1] IPO Details - The company intends to list on NASDAQ under the ticker symbol "AED" [1] - Maxim Group LLC is the exclusive bookrunner for this transaction [1]
香港医疗设备采购商栢威医药(AED.US)申请美股IPO，拟筹资700万美元
Zhi Tong Cai Jing·2025-12-15 09:01